← Back to Search

Cultural Adaptation of STAR-C for Dementia Caregivers

N/A
Recruiting
Led By Magaly Ramirez, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 years or older
Provide at least eight hours of care per week
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

Study Summary

This trial will develop a culturally adapted smartphone app to deliver the STAR-C training to Latino caregivers with the hope that it will be an acceptable and effective means of reducing caregiver burden and depression.

Who is the study for?
This trial is for Latino caregivers aged 18 or older who are family members or friends of someone with Alzheimer's Disease or Dementia, providing at least eight hours of care weekly. Participants must speak English or Spanish and self-identify as Latino. Caregivers with a diagnosis of ADRD cannot participate.Check my eligibility
What is being tested?
The study tests a smartphone app delivering culturally adapted STAR-C training to Latino caregivers. The app includes cultural examples, values, and idioms tailored to the community. It aims to be user-friendly and help reduce caregiver burden and depression.See study design
What are the potential side effects?
Since this intervention involves educational training via an app, there are no direct medical side effects like those associated with medications; however, participants may experience emotional discomfort while engaging in the training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I provide at least 8 hours of care weekly.
Select...
I speak English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Potential Effectiveness

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The investigators will recruit 15 Latino caregivers for each study arm (total sample size of 30). The sample size was based on a rule of thumb of 12 to 15 participants per group for pilot studies. This group will have access to the app.
Group II: ControlActive Control1 Intervention
12 to 15 participants, will not have access to the app.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,740 Previous Clinical Trials
1,847,610 Total Patients Enrolled
Alzheimer's AssociationOTHER
90 Previous Clinical Trials
40,713 Total Patients Enrolled
Magaly Ramirez, PhDPrincipal Investigator - University of Washington
University of Washington

Media Library

STAR-C Virtual Training and Follow-up (STAR-VTF) Clinical Trial Eligibility Overview. Trial Name: NCT04633408 — N/A
Alzheimer's Disease Research Study Groups: Intervention, Control
Alzheimer's Disease Clinical Trial 2023: STAR-C Virtual Training and Follow-up (STAR-VTF) Highlights & Side Effects. Trial Name: NCT04633408 — N/A
STAR-C Virtual Training and Follow-up (STAR-VTF) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04633408 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have joined the research study thus far?

"Affirmative. The information available on clinicaltrials.gov reveals that this medical trial, first posted on July 1st 2020, is presently seeking participants. A total of 60 people must be enlisted from 2 different healthcare facilities."

Answered by AI

Are there any vacancies in this research that participants could avail of?

"As per the clinicaltrials.gov registry, this trial commenced recruitment on July 1st 2020 and was most recently updated on November 21st 2022 - it is presently open for patient enrolment."

Answered by AI
~3 spots leftby Jun 2024